CDIO
NASDAQ · Biotechnology
Cardio Diagnostics Holdings
$1.68
-0.11 (-6.15%)
Open$1.87
Previous Close$1.79
Day High$1.88
Day Low$1.68
52W High$7.91
52W Low$0.97
Volume—
Avg Volume87.8K
Market Cap4.97M
P/E Ratio—
EPS$-3.72
SectorBiotechnology
Analyst Ratings
Strong Buy
7 analysts
Price Target
+1,866.1% upside
Current
$1.68
$1.68
Target
$33.03
$33.03
$21.42
$33.03 avg
$37.66
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 25.2K | 758.5K | 743.9K |
| Net Income | -10,980,222 | -209,998 | -203,473 |
| Profit Margin | -43,817.7% | -27.7% | -27.4% |
| EBITDA | -10,846,158 | -263,366 | -243,311 |
| Free Cash Flow | — | -217,938 | -231,433 |
| Rev Growth | — | -7.2% | +1.3% |
| Debt/Equity | 0.04 | 0.72 | 0.58 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $210.39 | -0.18% | 88.1 | 372.39B |
| AMGN | Amgen Inc | $326.31 | -2.95% | 23.0 | 179.23B |
| GILD | Gilead Sciences Inc | $129.58 | -1.88% | 17.4 | 160.50B |
| VRTX | Vertex Pharmaceuticals Inc | $436.95 | -2.99% | 26.4 | 114.32B |
| REGN | Regeneron Pharmaceuticals | $698.25 | -2.05% | 16.7 | 73.89B |
| ALNY | Alnylam Pharmaceuticals Inc | $286.98 | -2.20% | 66.6 | 38.43B |